<DOC>
	<DOCNO>NCT01424878</DOCNO>
	<brief_summary>Background : Medullary thyroid carcinoma ( MTC ) rare malignancy , occur either sporadic disease ( 75 % case ) , hereditary pattern multiple endocrine neoplasia ( MEN ) type 2 ( MEN2A MEN2B ) familial medullary thyroid carcinoma ( FMTC ) . The MTC arise neural crest C-cells hereditary case first pathological disorder C-cell hyperplasia ( CCH ) Most patient MTC advance disease time diagnosis . Chemotherapy external beam radiotherapy minimally effective . Molecular target therapeutic ( MTTs ) receptor kinases patient advanced MTC demonstrate activity . Despite clinical response , collection tumor tissue autologous normal tissue virtually non-existent . Thus , laboratory study define affect molecular target downstream pathway , molecular data provide direction future clinical trial yet occur . Data molecular study tumor tissue hereditary sporadic MTC patient assist predict clinical behavior biology MTC predict response give MTT , design combination clinical trial . Objectives : Clarify normal molecular pathway alter mutation RET protooncogene . Including additional genetic mutation unidentified chromosomal translocation . Correlate result molecular analysis MTC tissue patient clinical course . Define molecular clinical data useful designing target therapy patient MTC . Eligibility : Patients must confirm diagnosis C-cell hyperplasia , primary MTC , metastatic MTC archive pathology specimen available Washington University . Design : Paraffin block MTC tissue archival sample Washington University Department Pathology select . H &amp; E slide select tissue block examine molecular study suitability . Necessary tissue sample block molecular study , include , gene array , array comparative genomic hybridization , immunohistochemistry , sequence . Retrospective chart review occur obtain relevant clinical information .</brief_summary>
	<brief_title>Study Molecular Pathways Medullary Thyroid Carcinoma Correlation Molecular Data With Clinical Behavior MTC Individuals Patients</brief_title>
	<detailed_description>Background : Medullary thyroid carcinoma ( MTC ) rare malignancy , occur either sporadic disease ( 75 % case ) , hereditary pattern multiple endocrine neoplasia ( MEN ) type 2 ( MEN2A MEN2B ) familial medullary thyroid carcinoma ( FMTC ) . The MTC arise neural crest C-cells hereditary case first pathological disorder C-cell hyperplasia ( CCH ) Most patient MTC advance disease time diagnosis . Chemotherapy external beam radiotherapy minimally effective . Molecular target therapeutic ( MTTs ) receptor kinases patient advanced MTC demonstrate activity . Despite clinical response , collection tumor tissue autologous normal tissue virtually non-existent . Thus , laboratory study define affect molecular target downstream pathway , molecular data provide direction future clinical trial yet occur . Data molecular study tumor tissue hereditary sporadic MTC patient assist predict clinical behavior biology MTC predict response give MTT , design combination clinical trial . Objectives : Clarify normal molecular pathway alter mutation RET protooncogene . Including additional genetic mutation unidentified chromosomal translocation . Correlate result molecular analysis MTC tissue patient clinical course . Define molecular clinical data useful designing target therapy patient MTC . Eligibility : Patients must confirm diagnosis C-cell hyperplasia , primary MTC , metastatic MTC archive pathology specimen available Washington University . Design : Paraffin block MTC tissue archival sample Washington University Department Pathology select . H &amp; E slide select tissue block examine molecular study suitability . Necessary tissue sample block molecular study , include , gene array , array comparative genomic hybridization , immunohistochemistry , sequence . Retrospective chart review occur obtain relevant clinical information .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Thyroid Diseases</mesh_term>
	<mesh_term>Thyroid Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Neuroendocrine</mesh_term>
	<mesh_term>Endocrine Gland Neoplasms</mesh_term>
	<mesh_term>Multiple Endocrine Neoplasia</mesh_term>
	<mesh_term>Multiple Endocrine Neoplasia Type 2a</mesh_term>
	<criteria>INCLUSION CRITERIA : Patients must confirm diagnosis Ccell hyperplasia , primary MTC , metastatic MTC archive pathology specimen available Washington University .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 12, 2014</verification_date>
	<keyword>Molecular Analysis Medullary Thyroid Carcinoma Tissues</keyword>
</DOC>